Novel epigenetic therapy to treat mantle cell lymphoma
Scientists at Bellvitge Biomedical Research Institute have developed a small molecule epigenetic drug, targeting HDAC6, which could slow down cell growth in mantle cell lymphoma.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.